nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ACE—polycystic ovary syndrome	0.846	1	CbGaD
Cilazapril—ACE—tunica intima—polycystic ovary syndrome	0.0193	0.284	CbGeAlD
Cilazapril—ACE—urine—polycystic ovary syndrome	0.00951	0.14	CbGeAlD
Cilazapril—Azotaemia—Metformin—polycystic ovary syndrome	0.00478	0.069	CcSEcCtD
Cilazapril—SLC15A1—endometrium—polycystic ovary syndrome	0.00314	0.0462	CbGeAlD
Cilazapril—Rigors—Metformin—polycystic ovary syndrome	0.00312	0.045	CcSEcCtD
Cilazapril—ACE—embryo—polycystic ovary syndrome	0.00307	0.0452	CbGeAlD
Cilazapril—Blood disorder—Metformin—polycystic ovary syndrome	0.00305	0.044	CcSEcCtD
Cilazapril—SLC15A1—vagina—polycystic ovary syndrome	0.00235	0.0346	CbGeAlD
Cilazapril—ACE—endometrium—polycystic ovary syndrome	0.00225	0.0331	CbGeAlD
Cilazapril—SLC15A1—endocrine gland—polycystic ovary syndrome	0.0022	0.0324	CbGeAlD
Cilazapril—ACE—pituitary gland—polycystic ovary syndrome	0.00204	0.03	CbGeAlD
Cilazapril—ACE—adipose tissue—polycystic ovary syndrome	0.00203	0.0298	CbGeAlD
Cilazapril—SLC15A2—endometrium—polycystic ovary syndrome	0.00196	0.0289	CbGeAlD
Cilazapril—Renal impairment—Metformin—polycystic ovary syndrome	0.00194	0.028	CcSEcCtD
Cilazapril—ACE—adrenal gland—polycystic ovary syndrome	0.00182	0.0268	CbGeAlD
Cilazapril—Migraine—Metformin—polycystic ovary syndrome	0.00182	0.0263	CcSEcCtD
Cilazapril—ACE—Metabolism of Angiotensinogen to Angiotensins—CPB2—polycystic ovary syndrome	0.0018	0.254	CbGpPWpGaD
Cilazapril—SLC15A2—pituitary gland—polycystic ovary syndrome	0.00178	0.0261	CbGeAlD
Cilazapril—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00171	0.0246	CcSEcCtD
Cilazapril—ACE—female gonad—polycystic ovary syndrome	0.0017	0.025	CbGeAlD
Cilazapril—SLC15A2—adrenal gland—polycystic ovary syndrome	0.00159	0.0233	CbGeAlD
Cilazapril—ACE—endocrine gland—polycystic ovary syndrome	0.00158	0.0232	CbGeAlD
Cilazapril—Pancreatitis—Metformin—polycystic ovary syndrome	0.00157	0.0226	CcSEcCtD
Cilazapril—Angina pectoris—Metformin—polycystic ovary syndrome	0.00155	0.0225	CcSEcCtD
Cilazapril—Sweating increased—Metformin—polycystic ovary syndrome	0.00155	0.0225	CcSEcCtD
Cilazapril—Neutropenia—Metformin—polycystic ovary syndrome	0.00149	0.0216	CcSEcCtD
Cilazapril—SLC15A2—female gonad—polycystic ovary syndrome	0.00148	0.0218	CbGeAlD
Cilazapril—SLC15A2—vagina—polycystic ovary syndrome	0.00147	0.0216	CbGeAlD
Cilazapril—SLC15A2—endocrine gland—polycystic ovary syndrome	0.00138	0.0202	CbGeAlD
Cilazapril—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00135	0.0194	CcSEcCtD
Cilazapril—Bradycardia—Metformin—polycystic ovary syndrome	0.0013	0.0188	CcSEcCtD
Cilazapril—Rhinitis—Metformin—polycystic ovary syndrome	0.00128	0.0185	CcSEcCtD
Cilazapril—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00127	0.0184	CcSEcCtD
Cilazapril—Flushing—Metformin—polycystic ovary syndrome	0.00119	0.0171	CcSEcCtD
Cilazapril—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00119	0.0171	CcSEcCtD
Cilazapril—Angiopathy—Metformin—polycystic ovary syndrome	0.00116	0.0167	CcSEcCtD
Cilazapril—Immune system disorder—Metformin—polycystic ovary syndrome	0.00115	0.0167	CcSEcCtD
Cilazapril—Chills—Metformin—polycystic ovary syndrome	0.00115	0.0166	CcSEcCtD
Cilazapril—Flatulence—Metformin—polycystic ovary syndrome	0.0011	0.0158	CcSEcCtD
Cilazapril—Dysgeusia—Metformin—polycystic ovary syndrome	0.00109	0.0157	CcSEcCtD
Cilazapril—ABCB1—embryo—polycystic ovary syndrome	0.00108	0.0159	CbGeAlD
Cilazapril—Muscle spasms—Metformin—polycystic ovary syndrome	0.00107	0.0154	CcSEcCtD
Cilazapril—Fosinopril—ACE—polycystic ovary syndrome	0.00107	0.108	CrCbGaD
Cilazapril—Tremor—Metformin—polycystic ovary syndrome	0.00104	0.015	CcSEcCtD
Cilazapril—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00103	0.0149	CcSEcCtD
Cilazapril—Malaise—Metformin—polycystic ovary syndrome	0.001	0.0145	CcSEcCtD
Cilazapril—Syncope—Metformin—polycystic ovary syndrome	0.000997	0.0144	CcSEcCtD
Cilazapril—Palpitations—Metformin—polycystic ovary syndrome	0.000983	0.0142	CcSEcCtD
Cilazapril—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000978	0.0141	CcSEcCtD
Cilazapril—Hypertension—Metformin—polycystic ovary syndrome	0.00096	0.0139	CcSEcCtD
Cilazapril—Myalgia—Metformin—polycystic ovary syndrome	0.000947	0.0137	CcSEcCtD
Cilazapril—Chest pain—Metformin—polycystic ovary syndrome	0.000947	0.0137	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00094	0.0136	CcSEcCtD
Cilazapril—Discomfort—Metformin—polycystic ovary syndrome	0.000936	0.0135	CcSEcCtD
Cilazapril—Oedema—Metformin—polycystic ovary syndrome	0.000908	0.0131	CcSEcCtD
Cilazapril—Shock—Metformin—polycystic ovary syndrome	0.000893	0.0129	CcSEcCtD
Cilazapril—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000889	0.0128	CcSEcCtD
Cilazapril—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000887	0.0131	CbGeAlD
Cilazapril—Skin disorder—Metformin—polycystic ovary syndrome	0.000882	0.0127	CcSEcCtD
Cilazapril—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000878	0.0127	CcSEcCtD
Cilazapril—Perindopril—ACE—polycystic ovary syndrome	0.00087	0.0876	CrCbGaD
Cilazapril—Anorexia—Metformin—polycystic ovary syndrome	0.000865	0.0125	CcSEcCtD
Cilazapril—Spirapril—ACE—polycystic ovary syndrome	0.00086	0.0867	CrCbGaD
Cilazapril—Hypotension—Metformin—polycystic ovary syndrome	0.000848	0.0122	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000827	0.0119	CcSEcCtD
Cilazapril—Moexipril—ACE—polycystic ovary syndrome	0.000824	0.0831	CrCbGaD
Cilazapril—Mitiglinide—PPARG—polycystic ovary syndrome	0.000821	0.0828	CrCbGaD
Cilazapril—Benazepril—MTHFR—polycystic ovary syndrome	0.000818	0.0824	CrCbGaD
Cilazapril—Paraesthesia—Metformin—polycystic ovary syndrome	0.000815	0.0118	CcSEcCtD
Cilazapril—Dyspnoea—Metformin—polycystic ovary syndrome	0.000809	0.0117	CcSEcCtD
Cilazapril—Somnolence—Metformin—polycystic ovary syndrome	0.000807	0.0117	CcSEcCtD
Cilazapril—Dyspepsia—Metformin—polycystic ovary syndrome	0.000799	0.0115	CcSEcCtD
Cilazapril—ABCB1—endometrium—polycystic ovary syndrome	0.000792	0.0117	CbGeAlD
Cilazapril—Decreased appetite—Metformin—polycystic ovary syndrome	0.000789	0.0114	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000784	0.0113	CcSEcCtD
Cilazapril—Fatigue—Metformin—polycystic ovary syndrome	0.000783	0.0113	CcSEcCtD
Cilazapril—Constipation—Metformin—polycystic ovary syndrome	0.000776	0.0112	CcSEcCtD
Cilazapril—Quinapril—ACE—polycystic ovary syndrome	0.000766	0.0772	CrCbGaD
Cilazapril—Lisinopril—ACE—polycystic ovary syndrome	0.000766	0.0772	CrCbGaD
Cilazapril—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000748	0.0108	CcSEcCtD
Cilazapril—Ramipril—ACE—polycystic ovary syndrome	0.000742	0.0748	CrCbGaD
Cilazapril—Trandolapril—ACE—polycystic ovary syndrome	0.000742	0.0748	CrCbGaD
Cilazapril—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000742	0.0107	CcSEcCtD
Cilazapril—ABCB1—uterus—polycystic ovary syndrome	0.00073	0.0107	CbGeAlD
Cilazapril—Urticaria—Metformin—polycystic ovary syndrome	0.000721	0.0104	CcSEcCtD
Cilazapril—Abdominal pain—Metformin—polycystic ovary syndrome	0.000718	0.0104	CcSEcCtD
Cilazapril—ABCB1—pituitary gland—polycystic ovary syndrome	0.000717	0.0105	CbGeAlD
Cilazapril—ABCB1—adipose tissue—polycystic ovary syndrome	0.000714	0.0105	CbGeAlD
Cilazapril—Benazepril—ACE—polycystic ovary syndrome	0.000667	0.0672	CrCbGaD
Cilazapril—Asthenia—Metformin—polycystic ovary syndrome	0.000651	0.00941	CcSEcCtD
Cilazapril—Pruritus—Metformin—polycystic ovary syndrome	0.000642	0.00927	CcSEcCtD
Cilazapril—ABCB1—adrenal gland—polycystic ovary syndrome	0.00064	0.00942	CbGeAlD
Cilazapril—ACE—Peptide hormone metabolism—CGB5—polycystic ovary syndrome	0.000625	0.0881	CbGpPWpGaD
Cilazapril—Diarrhoea—Metformin—polycystic ovary syndrome	0.000621	0.00897	CcSEcCtD
Cilazapril—Dizziness—Metformin—polycystic ovary syndrome	0.0006	0.00867	CcSEcCtD
Cilazapril—ABCB1—female gonad—polycystic ovary syndrome	0.000597	0.00878	CbGeAlD
Cilazapril—ABCB1—vagina—polycystic ovary syndrome	0.000593	0.00873	CbGeAlD
Cilazapril—Vomiting—Metformin—polycystic ovary syndrome	0.000577	0.00834	CcSEcCtD
Cilazapril—Rash—Metformin—polycystic ovary syndrome	0.000572	0.00827	CcSEcCtD
Cilazapril—Dermatitis—Metformin—polycystic ovary syndrome	0.000572	0.00826	CcSEcCtD
Cilazapril—Headache—Metformin—polycystic ovary syndrome	0.000569	0.00821	CcSEcCtD
Cilazapril—Enalapril—ACE—polycystic ovary syndrome	0.000563	0.0567	CrCbGaD
Cilazapril—ABCB1—endocrine gland—polycystic ovary syndrome	0.000555	0.00817	CbGeAlD
Cilazapril—Nausea—Metformin—polycystic ovary syndrome	0.000539	0.00779	CcSEcCtD
Cilazapril—ACE—Peptide hormone metabolism—CPB2—polycystic ovary syndrome	0.000474	0.0667	CbGpPWpGaD
Cilazapril—Nateglinide—PPARG—polycystic ovary syndrome	0.000418	0.0422	CrCbGaD
Cilazapril—ACE—Peptide hormone metabolism—INHBB—polycystic ovary syndrome	0.000359	0.0506	CbGpPWpGaD
Cilazapril—ABCB1—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.000273	0.0385	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—LHB—polycystic ovary syndrome	0.000266	0.0374	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—polycystic ovary syndrome	0.00019	0.0268	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.000175	0.0247	CbGpPWpGaD
Cilazapril—ABCB1—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000164	0.0231	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.000163	0.023	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.000118	0.0166	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.000108	0.0152	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.000106	0.0149	CbGpPWpGaD
Cilazapril—ABCB1—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	9.9e-05	0.0139	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	9.1e-05	0.0128	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	9.07e-05	0.0128	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—INS—polycystic ovary syndrome	9.02e-05	0.0127	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	8.95e-05	0.0126	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CPB2—polycystic ovary syndrome	8.95e-05	0.0126	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	8.72e-05	0.0123	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	8.44e-05	0.0119	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—INHBB—polycystic ovary syndrome	6.78e-05	0.00955	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB1—polycystic ovary syndrome	6.48e-05	0.00913	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	6.48e-05	0.00913	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	6.08e-05	0.00857	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	6.02e-05	0.00847	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	5.86e-05	0.00826	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—polycystic ovary syndrome	5.69e-05	0.00802	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	5.44e-05	0.00766	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—LHB—polycystic ovary syndrome	5.02e-05	0.00706	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FOXP3—polycystic ovary syndrome	4.98e-05	0.00701	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—TFRC—polycystic ovary syndrome	4.52e-05	0.00637	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	4.48e-05	0.00632	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	4.09e-05	0.00577	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	3.8e-05	0.00535	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	3.75e-05	0.00528	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—LMNA—polycystic ovary syndrome	3.72e-05	0.00523	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—GHRL—polycystic ovary syndrome	3.31e-05	0.00466	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	3.08e-05	0.00434	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	2.85e-05	0.00402	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	2.79e-05	0.00393	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	2.53e-05	0.00356	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.45e-05	0.00345	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.27e-05	0.0032	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.27e-05	0.0032	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.11e-05	0.00297	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.08e-05	0.00293	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	2.03e-05	0.00286	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—LEP—polycystic ovary syndrome	1.99e-05	0.00281	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	1.99e-05	0.0028	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	1.93e-05	0.00272	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.93e-05	0.00272	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	1.84e-05	0.00259	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.75e-05	0.00246	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—POMC—polycystic ovary syndrome	1.71e-05	0.00241	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—INS—polycystic ovary syndrome	1.7e-05	0.0024	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—IGF1—polycystic ovary syndrome	1.65e-05	0.00232	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.62e-05	0.00228	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	1.5e-05	0.00212	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	1.37e-05	0.00192	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	1.28e-05	0.0018	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	1.19e-05	0.00168	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	1.18e-05	0.00167	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	1.09e-05	0.00153	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	1.09e-05	0.00153	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	1.01e-05	0.00143	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	8.94e-06	0.00126	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	8.62e-06	0.00121	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	8.62e-06	0.00121	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	7.8e-06	0.0011	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	7.68e-06	0.00108	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	7.22e-06	0.00102	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.14e-06	0.00101	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	6.84e-06	0.000964	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—STAR—polycystic ovary syndrome	6.53e-06	0.00092	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	6.53e-06	0.000919	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	5.84e-06	0.000822	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	5.82e-06	0.00082	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	5.55e-06	0.000782	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.48e-06	0.000771	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LHB—polycystic ovary syndrome	5.06e-06	0.000713	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	4.95e-06	0.000697	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	4.79e-06	0.000675	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	4.41e-06	0.000621	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	4.27e-06	0.000602	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	4.12e-06	0.00058	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	3.96e-06	0.000557	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	3.91e-06	0.00055	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	3.69e-06	0.00052	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	3.63e-06	0.000511	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TH—polycystic ovary syndrome	3.14e-06	0.000443	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	3.06e-06	0.000431	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	2.87e-06	0.000405	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	2.57e-06	0.000361	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	2.44e-06	0.000344	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	2.32e-06	0.000326	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	2.16e-06	0.000304	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.75e-06	0.000247	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.73e-06	0.000243	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.72e-06	0.000242	CbGpPWpGaD
